Unravel Biosciences
PrivateLast Round
Seed Round
Aug 7, 2026
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Unravel Biosciences is a biotechnology company that provides an artificial intelligence-driven systems biology platform designed to discover and clinically validate therapeutic targets for complex diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Unravel Biosciences Comparables
Compare Unravel Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Transcripta Bio | 85% | |
| Scripta Therapeutics | 80% | |
| Aitia | 79% |
Unravel Biosciences Funding Rounds
Historical fundraising activity
Unravel Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RTK Group | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 7, 2026
$4.1M raised in Seed Round.
- Jul 25, 2026
Monthly visitors grew 57% MoM, reaching 3.3K.
Unravel Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Unravel Biosciences's valuation, stock price, and market status.
Is Unravel Biosciences a public or private company?
Unravel Biosciences is a private company.
What is the current stock price of Unravel Biosciences?
Unravel Biosciences is a private company, so its shares have no public market price. Caplight tracks Unravel Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Unravel Biosciences worth (valuation)?
Valuation information for Unravel Biosciences is not publicly available.
Can I buy Unravel Biosciences stock?
Unravel Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Unravel Biosciences's last funding round?
Unravel Biosciences's most recent funding round was Seed Round on August 7, 2026.
Who are the main investors in Unravel Biosciences?
Key investors in Unravel Biosciences include RTK Group.
Will Unravel Biosciences IPO soon?
No public IPO plans have been announced for Unravel Biosciences.
How can I track Unravel Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Unravel Biosciences's shares on secondary markets.